abrdn Life Sciences Investors
HQL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$560.72M
Close$
$-0.64
103.5% downside
Current Fair Value
103.5% downsideOvervalued by 103.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $560.72 Million |
|---|---|
| Enterprise Value | $560.72 Million |
| Annual dividend | $2.24 |
| Dividend yield | 12.15% |
| Earnings per Share | $2.96 |
| Beta | 0.73 |
| Outstanding Shares | 30,408,046 |
Return
| Return on Equity | 33.16% |
|---|---|
| Return on Assets | 33.02% |
| Return on Invested Capital | 26.57% |
Valuation & Multiples
| P/E Ratio | 2.73 |
|---|---|
| PEG | -1.15 |
| Price to Sales | 4.5 |
| Price to Book Ratio | 1.0 |
| Enterprise Value to Revenue | 4.11 |
| Enterprise Value to EBIT | 3.75 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.17%▼ 23.79% |
|---|---|
| Total Invested | $12.32M▼ 92.15% |
| Investors Holding | 13▼ 75.00% |
About Tekla Life Sciences Investors
Tekla Life Sciences Investors is a closed-end fund that invests in public and private companies in the life sciences industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund.